Thank you very much, Mr. Chair.
I want to speak to Madam Yeates and I'm going to be focusing on transparency. First I want to clarify a few things with Mr. Maxwell.
When a department heartily agrees with all of the recommendations, this is what makes Canada wonderful. This is what makes our bureaucracy a model for the world. We listen and we work in partnership to make things better for all Canadians. I compliment the work of the Auditor General, always.
Was this your first review, Mr. Maxwell, of the responsibilities for pharmaceutical drugs in regard to transparency and consistency?